Medicine overview
Erlotinib is a tyrosine kinase inhibitor (TKI) which is a type of cancer growth blocker. It blocks proteins on cancer cells that encourage the cancer to grow.




We'll only use your email for the alerts you choose. See our Privacy Policy.
Have a question? Message our team directly.